Search for other papers by Marta Araujo-Castro in
Google Scholar
PubMed
Search for other papers by Héctor Pian in
Google Scholar
PubMed
Search for other papers by Ignacio Ruz-Caracuel in
Google Scholar
PubMed
Search for other papers by Alberto Acitores Cancela in
Google Scholar
PubMed
Search for other papers by Eider Pascual-Corrales in
Google Scholar
PubMed
Endoscopic Skull Base Unit, Department of Neurosurgery, Hospital Universitario HM Puerta del Sur, Madrid, Spain
Search for other papers by Víctor Rodríguez Berrocal in
Google Scholar
PubMed
IGF1 levels ( 9 ) and induce tumor shrinkage ( 10 ), improving surgical outcomes in acromegaly ( 11 , 12 , 13 ). However, the impact of SRLs in the GH-secreting pituitary tumor consistency has yet to be elucidated, and controversial results have been
Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Search for other papers by Xiaohui Qi in
Google Scholar
PubMed
Search for other papers by Ping He in
Google Scholar
PubMed
Search for other papers by Huayan Yao in
Google Scholar
PubMed
Search for other papers by Huanhuan Sun in
Google Scholar
PubMed
Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Search for other papers by Jiying Qi in
Google Scholar
PubMed
Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Search for other papers by Min Cao in
Google Scholar
PubMed
Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Search for other papers by Bin Cui in
Google Scholar
PubMed
Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Search for other papers by Guang Ning in
Google Scholar
PubMed
shown that insulin and insulin-like growth factor (IGF) are involved in the development and progression of malignancies ( 9 , 10 ). Insulin has been reported to be associated with an increased risk of several cancer sites, such as the liver, pancreas
Search for other papers by Yanfei Chen in
Google Scholar
PubMed
Search for other papers by Mei Li in
Google Scholar
PubMed
Search for other papers by Binrong Liao in
Google Scholar
PubMed
Search for other papers by Jingzi Zhong in
Google Scholar
PubMed
Search for other papers by Dan Lan in
Google Scholar
PubMed
, insulin-like growth factor-1 (IGF-1), insulin) have shown potential roles in the diagnosis of CPP ( 10 , 11 , 12 ). Recently, Kutlu et al. ( 13 ) reported the role of another novel adipomyokine, irisin, in the diagnosis of CPP, and their study implied
Search for other papers by Danielle Christine Maria van der Kaay in
Google Scholar
PubMed
Search for other papers by Anne Rochtus in
Google Scholar
PubMed
Search for other papers by Gerhard Binder in
Google Scholar
PubMed
Search for other papers by Ingo Kurth in
Google Scholar
PubMed
Search for other papers by Dirk Prawitt in
Google Scholar
PubMed
Search for other papers by Irène Netchine in
Google Scholar
PubMed
Department of Endocrinology at Sahlgrenska University Hospital, Gothenburg, Sweden
Search for other papers by Gudmundur Johannsson in
Google Scholar
PubMed
Search for other papers by Anita C S Hokken-Koelega in
Google Scholar
PubMed
Search for other papers by Miriam Elbracht in
Google Scholar
PubMed
Search for other papers by Thomas Eggermann in
Google Scholar
PubMed
radiologic and clinical examinations suggest an endocrine cause of the growth disturbance, growth hormone stimulation tests (GHSTs), serum insulin-like growth factor (IGF1), and sometimes an IGF1 generation test are used to investigate the growth hormone (GH)–IGF
School of Medicine, Western Sydney University, Sydney, Australia
Search for other papers by Prishila Fookeerah in
Google Scholar
PubMed
Westmead Clinical School, University of Sydney, Sydney, Australia
Search for other papers by Winny Varikatt in
Google Scholar
PubMed
Westmead Clinical School, University of Sydney, Sydney, Australia
Search for other papers by Meena Shingde in
Google Scholar
PubMed
Department of Neurosurgery, Westmead Hospital, Sydney, Australia
Search for other papers by Mark A J Dexter in
Google Scholar
PubMed
School of Medicine, Western Sydney University, Sydney, Australia
Search for other papers by Mark McLean in
Google Scholar
PubMed
secretion. All eight tumours causing acromegaly expressed growth hormone (GH) and produced elevated insulin-like growth factor 1 (IGF-1) levels (mean 3.1× upper limit of normal). Of these, six tumours expressed prolactin, but none caused high serum prolactin
Department of Emergency Medicine, Landspitali – The National University Hospital of Iceland, Reykjavik, Iceland
Search for other papers by Lára Ósk Eggertsdóttir Claessen in
Google Scholar
PubMed
Search for other papers by Hafrún Kristjánsdóttir in
Google Scholar
PubMed
Department of Psychology, School of Social Sciences, Reykjavik University, Reykjavik, Iceland
Search for other papers by María Kristín Jónsdóttir in
Google Scholar
PubMed
School of Engineering and Natural Sciences, University of Iceland, Reykjavik, Iceland
Search for other papers by Sigrún Helga Lund in
Google Scholar
PubMed
Search for other papers by Ingunn Unnsteinsdóttir Kristensen in
Google Scholar
PubMed
Department of Medicine, Landspitali – The National University Hospital of Iceland, Reykjavik, Iceland
Search for other papers by Helga Ágústa Sigurjónsdóttir in
Google Scholar
PubMed
expensive, a biochemical marker for GHD screening would be beneficial. Serum insulin-like growth factor 1 (s-IGF1) has been proposed as a screening tool for GHD as low s-IGF1 may indicate GHD. However, its use remains debatable as s-IGF1 within normal range
Search for other papers by Nathalia Liberatoscioli Menezes Andrade in
Google Scholar
PubMed
Search for other papers by Mariana Ferreira de Assis Funari in
Google Scholar
PubMed
Search for other papers by Alexsandra Christianne Malaquias in
Google Scholar
PubMed
Search for other papers by Paulo Ferrez Collett-Solberg in
Google Scholar
PubMed
Search for other papers by Nathalia L R A Gomes in
Google Scholar
PubMed
Departamento de Medicina, Faculdade de Ciencias Medicas da Santa Casa de Sao Paulo, Sao Paulo, Brasil
Search for other papers by Renata Scalco in
Google Scholar
PubMed
Search for other papers by Naiara Castelo Branco Dantas in
Google Scholar
PubMed
Search for other papers by Raissa C Rezende in
Google Scholar
PubMed
Search for other papers by Angelica M F P Tiburcio in
Google Scholar
PubMed
Search for other papers by Micheline A R Souza in
Google Scholar
PubMed
Unidade de Endocrinologia do Desenvolvimento, Laboratorio de Hormonios e Genetica Molecular (LIM42), Hospital das Clinicas da Faculdade de Medicina, Universidade de Sao Paulo (USP), Sao Paulo, Brasil
Search for other papers by Bruna L Freire in
Google Scholar
PubMed
Search for other papers by Ana C V Krepischi in
Google Scholar
PubMed
Search for other papers by Carlos Alberto Longui in
Google Scholar
PubMed
Search for other papers by Antonio Marcondes Lerario in
Google Scholar
PubMed
Search for other papers by Ivo J P Arnhold in
Google Scholar
PubMed
Unidade de Endocrinologia do Desenvolvimento, Laboratorio de Hormonios e Genetica Molecular (LIM42), Hospital das Clinicas da Faculdade de Medicina, Universidade de Sao Paulo (USP), Sao Paulo, Brasil
Search for other papers by Alexander A L Jorge in
Google Scholar
PubMed
Unidade de Endocrinologia do Desenvolvimento, Laboratorio de Hormonios e Genetica Molecular (LIM42), Hospital das Clinicas da Faculdade de Medicina, Universidade de Sao Paulo (USP), Sao Paulo, Brasil
Search for other papers by Gabriela Andrade Vasques in
Google Scholar
PubMed
short stature in patients initially classified as ISS ( 7 ). The genetic defects associated with ISS are mainly located in genes that regulate the endochondral ossification process in the growth plate and in genes related to the GH–IGF-1 axis ( 8 , 9
Search for other papers by Charlotte Höybye in
Google Scholar
PubMed
Search for other papers by Beverly M K Biller in
Google Scholar
PubMed
Search for other papers by Jean-Marc Ferran in
Google Scholar
PubMed
Search for other papers by Murray B Gordon in
Google Scholar
PubMed
Search for other papers by Nicky Kelepouris in
Google Scholar
PubMed
Search for other papers by Navid Nedjatian in
Google Scholar
PubMed
Search for other papers by Anne H Olsen in
Google Scholar
PubMed
Search for other papers by Matthias M Weber in
Google Scholar
PubMed
, n (%) 317 (44.7) Mean age, years ( s.d. ) ( n = 683) 47.0 (14.0) Mean IGF-I SDS ( s.d. ) ( n = 554) −1.16 (1.43) Mean BMI, kg/m 2 ( s.d. ) ( n = 608) 28.8 (6.2) Number of pituitary deficiencies, n
Search for other papers by Yu Ah Hong in
Google Scholar
PubMed
Search for other papers by Kyung-Do Han in
Google Scholar
PubMed
Search for other papers by Jae-Seung Yun in
Google Scholar
PubMed
Search for other papers by Eun Sil Sil in
Google Scholar
PubMed
Search for other papers by Seung-Hyun Ko in
Google Scholar
PubMed
Search for other papers by Sungjin Chung in
Google Scholar
PubMed
growth hormone/insulin-like growth factor-1 (GH/IGF-1) system. IGF-1 levels were reported to be positively associated with height ( 30 , 31 ). The kidney is a significant source of IGF-1 synthesis, some of which is released into circulation. In addition
Search for other papers by Alberto Battezzati in
Google Scholar
PubMed
Search for other papers by Andrea Foppiani in
Google Scholar
PubMed
Search for other papers by Gianfranco Alicandro in
Google Scholar
PubMed
Search for other papers by Arianna Bisogno in
Google Scholar
PubMed
Search for other papers by Arianna Biffi in
Google Scholar
PubMed
Internal Medicine, S. Maria delle Croci Hospital, AUSL Romagna, Ravenna, Italy
Search for other papers by Giorgio Bedogni in
Google Scholar
PubMed
Istituto Auxologico Italiano, IRCCS, Obesity Unit - Laboratory of Nutrition and Obesity Research, Department of Endocrine and Metabolic Diseases, Milan, Italy
Search for other papers by Simona Bertoli in
Google Scholar
PubMed
Search for other papers by Giulia De Carlo in
Google Scholar
PubMed
Search for other papers by Erica Nazzari in
Google Scholar
PubMed
Search for other papers by Carla Colombo in
Google Scholar
PubMed
studies in type 1 diabetes and in healthy subjects. According to mechanistic studies, insulin is one of the main regulators of growth hormone (GH)/insulin-like growth factor 1 (IGF-1) axis ( 21 ), frequently involved in growth failure associated with